Search Results 1651-1660 of 17838 for secondary infertility

1. A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics - Mayo Clinic

   The purpose of this research is to find out how genetic variations in GLP1R, alters insulin secretion, in the fasting state and when blood sugars levels are ...

2. A Study to Learn More About Experiences of Patients with Genetic Risk for Breast Cancer - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. A Study Of DdcfDNA For Kidney Transplant Monitoring - Mayo Clinic

   The purpose of this study is to clinically validate the use of GraftAssureDx as an assay for identifying kidney transplant patients with a low probability of ...

4. Gut Permeability Assessment in Celiac and Gluten Sensitive Children - Mayo Clinic

   This study will assess the effect of gluten on gut barrier function. Investigators at the Mayo Clinic have developed a new gut permeability test using rhamnose ...

5. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

   Lenalidomide may stimulate the immune system in different ways and stop cancer cells from growing. It is not yet known whether rituximab and combination ...

6. A Study to Compare Stereotactic Radiosurgery to Hippocampal-Avoidant Whole Brain Radiotherapy - Mayo Clinic

   The purpose of this study is to compare stereotactic radiosurgery (SRS) to whole brain radiotherapy (WBRT) in patients with 5 or more brain metastases.

7. Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers - Mayo Clinic

   Enzalutamide is not FDA approved to treat salivary gland cancer, but it has already been FDA-approved to treat other cancers. Participation eligibility.

8. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

   The purpose of this study is to characterize the safety profile of acalabrutinib and pembrolizumab in subjects with hematologic malignancies. Participation ...

9. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

   Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors, lymphomas, or multiple myeloma.

10. A Study of Genetic Markers in Patients with Suspected Cardiac Channelopathies - Mayo Clinic

    This study is being done to identify underlying genetic defects in individuals from families who are at-risk of a possible cardiac channelopathy (abnormal ...